Medical News

RSS

Ventirx VTX-1463 positive clinical data against allergic rhinitis presented at AAAAI meeting

VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 agonists and antagonists for the treatment of cancer, respiratory and autoimmune diseases, announced today the presentation of positive clinical results from its randomized, placebo-controlled clinical trial evaluating VTX-1463 for the treatment of allergic rhinitis.

22 Mar 2011

Rethink acknowledges Ontario's new breast cancer program

Rethink Breast Cancer acknowledges today's swift decision by the Ontario government to take steps towards providing greater access to specific cancer treatments.

22 Mar 2011

High sodium intake may increase risk of heart disease, stroke, kidney problem

Taking in too much sodium may turn out to be quite a salty situation. In fact, according to the Centers for Disease Control and Prevention, in 2010 high blood pressure cost the United States $76.6 billion in health care services, medications, and missed days of work.

22 Mar 2011

Senior Pentagon officials fight foreign aid cuts, The Hill reports

Senior Pentagon officials have expressed opposition to proposed foreign aid cuts, The Hill reports, highlighting the challenges they face in making their case to preserve this funding.

22 Mar 2011

Patients with bone cancer can benefit from radical surgery

During a radical surgery to treat a rare bone cancer, surgeons at UC San Diego Health System and Moores Cancer Center removed 50 percent of a patient's pelvis. Instead of amputating the connected leg, the surgical team, comprised of orthopaedic, vascular and urologic experts, saved the entire limb. The patient was able to walk with assistance five weeks after surgery.

22 Mar 2011

IOF, Fonterra Brands award 10,000 USD to OSPFI for Bone Health Campaign

The Osteoporosis Society of the Philippines Foundation Inc was awarded the first IOF-Anlene Nutrition Awareness for Bone Health Campaign Grant at a presentation ceremony that took place at the IOF World Wide Conference of Osteoporosis Patient Societies in Valencia, Spain on March 20, 2011.

22 Mar 2011

NYC expands YMCA's Diabetes Prevention Program to help adults avoid disease consequences

The YMCA of Greater New York today announced the New York City expansion of the YMCA's Diabetes Prevention Program, a 16-session group behavior change class that helps people at high risk for developing type 2 diabetes prevent the disease through healthy eating, increased activity and other positive lifestyle changes.

22 Mar 2011

Daily dose of safflower oil can help reduce cardiovascular disease

A daily dose of safflower oil, a common cooking oil, for 16 weeks can improve such health measures as good cholesterol, blood sugar, insulin sensitivity and inflammation in obese postmenopausal women who have Type 2 diabetes, according to new research.

22 Mar 2011

Scientists develop new method for gene regulation study

Scientists at the European Molecular Biology Laboratory in Heidelberg, Germany, have developed a new method for studying gene regulation, by employing a jumping gene as an informant. Published online today in Nature Genetics, the new method is called GROMIT.

22 Mar 2011

Study: Stem cell transplant may benefit patients with rapidly progressive MS

A long term study reports about the effectiveness of replacing bone marrow, purposely destroyed by chemotherapy, with autologous stem cell rescue for people with aggressive forms of multiple sclerosis.

22 Mar 2011

Polypill may serve as viable option for developing countries to treat CVD risk prevention

For a patient at high risk of cardiovascular disease, keeping up with what pills to take at different times of the day can be tedious. Window sills lined with prescription bottles - a pill for cholesterol, another for blood pressure, and an aspirin to keep blood thin and flowing - the list can get quite long and, as a result, many people, especially the elderly, often forget doses or take the wrong pill at the wrong time.

22 Mar 2011

PSN system can reduce psychiatric medication errors

Coupling an electronic prescription drug ordering system with a computerized method for reporting adverse events can dramatically reduce the number of medication errors in a hospital's psychiatric unit, suggests new Johns Hopkins research.

22 Mar 2011

Cordis launches new PTA Balloon Catheter to treat PAD

Cordis Corporation is pleased to announce the launch of SLEEK® OTW Catheter, a new .014" Percutaneous Transluminal Angioplasty Balloon Catheter designed to help physicians save limbs and enhance patients' lives.

22 Mar 2011

ACE, ARB combination therapy may increase risk of kidney failure, death

Elderly patients prescribed combination angiotensin converting enzyme inhibitors and angiotensin receptor blockers had a higher risk of kidney failure and death, according to a study published in CMAJ.

22 Mar 2011

Telecommunication engineer creates new child arrhythmias database

Ventricular Fibrillation is a series of intense and disordered contractions of the ventricles. In 40 % of respiratory arrests suffered outside a hospital, it was shown that the first cardiac rhythm corresponds to VF, and the only manner to combat it is with electric discharges provided by defibrillation.

22 Mar 2011

Stress can change balance of gut bacteria

Stress can change the balance of bacteria that naturally live in the gut, according to research published this month in the journal Brain, Behavior, and Immunity.

22 Mar 2011

CMU's CNAST receives DSF Charitable Foundation grant to develop novel biomedical tools

The DSF Charitable Foundation has given a $3.9 million grant to Carnegie Mellon University's Center for Nucleic Acids Science and Technology to further the development of novel biomedical tools targeted at monitoring and manipulating gene expression.

22 Mar 2011

FDA accepts Arisaph's ARI-3037MO IND for phase I human clinical trial

Arisaph Pharmaceuticals, Inc., a privately held drug discovery biopharmaceutical company, today announced that the U.S. Food and Drug Administration has accepted the Company's recently submitted Investigational New Drug application to evaluate ARI-3037MO in a phase I human clinical trial in healthy volunteers.

22 Mar 2011

BDSI's BEMA drug delivery technology receives Canada patent

BioDelivery Sciences International, Inc. announced the issuance of a patent extending the exclusivity of the BioErodible MucoAdhesive drug delivery technology in Canada from 2017 to 2027. The patent was been reviewed by the Office of Patented Medicines for listing in the Canadian Patent Register and was found eligible for listing.

22 Mar 2011

New research: Trauma patients treated on weekends have greater chance of survival

Patients who've been hurt in car or bike crashes, been shot or stabbed, or suffered other injuries are more likely to live if they arrive at the hospital on the weekend than during the week, according to new University of Pennsylvania School of Medicine research published in the March 21 issue of Archives of Surgery.

22 Mar 2011